Forbes January 16, 2026
A new immune cell therapy offers real hope for people with pancreatic cancer, a disease that has seen little progress and leaves most patients with only months to live. For decades, survival rates have barely changed, leaving patients and families with few real options. One of the latest immunotherapies, called CAR T, could change that story. It works by training a patient’s own immune cells to hunt down and attack cancer.
As described in my book, CAR T: A New Cure for Cancer, Autoimmune and Inherited Disease, these advances in immune cell therapy are changing the future of cancer care. This breakthrough for pancreatic cancer could shift what patients can expect from treatment, bringing genuine hope where it’s long been...
Today's Sponsors
Today's Sponsor